VivoSeq
Infectious Disease

Acute Bronchiolitis

9

Pipeline Programs↗

3

Active Trials↗

5

Companies Involved↗

Acute Bronchiolitis is an early-stage landscape with 9 programs across 5 companies. The most active players are Hyundai Pharmaceutical Co., LTD., Fresenius Kabi Oncology Ltd., ARS Pharmaceuticals, Inc.. 3 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

37/100

Pipeline Velocity

6/100

Mech. Concentration

50/100

Completion Rate

87/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

H

Hyundai Pharmaceutical Co., LTD.

1 program

Phase 2F

Fresenius Kabi Oncology Ltd.

1 program

Phase 3A

ARS Pharmaceuticals, Inc.

1 program

Phase 3M

Milestone Pharmaceuticals Inc.

1 program

ApprovedAstraZeneca logo

AstraZeneca

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

21

clinical trials

Completed13 · 62%
Unknown status3 · 14%
Not yet recruiting2 · 10%
Recruiting1 · 5%
Terminated1 · 5%
Withdrawn1 · 5%

Clinical Trials

Trial Activity

21 trials

Comparative Efficacy of Hypertonic Saline vs Adrenaline Nebulization in Acute Bronchiolitis
Recruiting·—·Phase 3·NCT06267118·60 enrolled
Nebulized 3% Hypertonic Saline Versus Normal Saline in Managing Children With Acute Bronchiolitis: A Randomized Controlled Trial
Not yet recruiting·UUniversity Of Anbar·N/A·NCT07138625·300 enrolled
Magnesium Sulfate in Bronchial Asthma and Acute Bronchiolitis in Children
Not yet recruiting·—·Phase 3·NCT06955559·60 enrolled
Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis
Completed·SSzpital im. Św. Jadwigi Śląskiej·N/A·NCT06069336·180 enrolled
Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants
Completed·UUniversity Hospital, Grenoble·Phase 4·NCT02538458·120 enrolled
Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
Completed·—·Phase 2/3·NCT06558461·140 enrolled
Hypertonic Saline for Acute Bronchiolitis
Completed·—·Phase 4·NCT01247064·62 enrolled
Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children
Completed·KKhon Kaen University·N/A·NCT00122785·170 enrolled
Trial of Montelukast for Treatment of Acute Bronchiolitis
Completed·MMedical College of Wisconsin·N/A·NCT00863317·141 enrolled
Single Dose Versus Multiple Doses of Dexamethasone in Children With Acute Bronchiolitis
Completed·TThe Hospital for Sick Children·Phase 3·NCT00213226·120 enrolled
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis
Completed·UUniversity of Texas Southwestern Medical Center·N/A·NCT02029040·52 enrolled
Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing
Completed·HHormozgan University of Medical Sciences·N/A·NCT01370187·146 enrolled
Vitamin D Supplementation for Acute Bronchiolitis
Completed·MMansoura University·Phase 2·NCT03799406·60 enrolled
The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
Completed·UUniversity of Utah·Phase 4·NCT00119002·598 enrolled
7% Hypertonic Saline for Acute Bronchiolitis
Completed·LLe Bonheur Children's Hospital·Phase 4·NCT01871857·101 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)